ArticlebioRxiv : the preprint server for biology2026
Optimizing phenotype scale improves genetic analyses in large-scale biobanks.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Large-scale biobanks have enabled increasingly complicated genetic analyses across thousands of phenotypes. However, studies rarely consider the appropriate phenotype measurement scale, a problem that can drastically affect inferences on genetic architecture. Here, we introduce SIQReg, a practical solution to this classical problem, which learns a data-driven phenotype scale by minimizing heterogeneity across phenotype quantiles. Applied to complex traits in UK Biobank, SIQReg rejects the default scale for 24/25 traits. Generally, SIQReg scales lie between default and logarithmic, indicating that default-scale traits are neither purely additive nor purely multiplicative. We show that SIQReg improves both non-additive and additive genetic analyses. SIQReg eliminates most non-additive genetic signals (such as 97% of vQTL and 76% of quantile-dependent TWAS genes), indicating they may be statistical artifacts, while preserving biologically plausible non-additive signals. Simultaneously, SIQReg improves power to detect additive signals, increasing GWAS loci, TWAS genes, and PGS prediction accuracy by 11%, 13%, and 10%, respectively, and identifies 50% more high-risk individuals. These gains replicate across ancestry groups. Our results establish SIQReg as a principled approach to phenotype scale transformation that improves genetic analyses of complex traits.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.